- Impact Measurement and Management Practice Leader
- Insights
- Capabilities
- Funds
- Sustainability
- About Us
- My Account
The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
Impact measurement and management (IMM) are two related but distinct practices that we believe are critical to effective impact investing. Impact measurement helps to identify and track both the positive and negative social or environmental impacts of a company’s products and services. Impact management uses this information to try to maximise positive outcomes for people and the planet.1
In this piece, we highlight how we view IMM, why venture capital (VC) matters to impact investors, how IMM can be applied to this asset class and how to authentically measure impact in venture capital.
At Wellington, a holistic assessment of impact is core to our investment process in both public and private markets where we are explicitly investing to drive real-world positive outcomes alongside strong financial returns. For these strategies, several IMM activities are central to the investment process, including clearly defining what impact criteria qualifies a company to be part of a portfolio ahead of each investment, conducting detailed research to evidence that the specified impact criteria can be met and, finally, reporting on and analysing this data to seek to maximise real-world positive impact.
The Global Impact Investing Network (GIIN) estimates that there are over US$715 billion impact investing assets under management globally. Notably, in its annual survey, 63% of respondents had an allocation to venture-stage companies, demonstrating that impact investors are deploying capital in this segment of the market.2
Many venture-stage companies are innovative, fast growing and on a mission to change the entire ecosystem in which they operate. Combining these characteristics with products and services aligned with making real-world positive social or environmental progress is an extremely attractive proposition for impact investors, particularly those looking to bring about widespread changes through their investments. The climate crisis represents a useful example here given that many venture-stage companies are developing new technologies that may play a key role in helping every sector of the economy transform by reducing energy consumption, increasing energy efficiency and making global energy supply more sustainable.
In addition, the next generation of entrepreneurs seeking venture capital may be more likely than the last to include sustainability considerations in their business models. In fact, entrepreneurs in their 20s and 30s are more likely than those in their 50s to view social impact as a personal motivation.3 A company’s positive impact is likely to become an increasingly important part of its mission and pitch to investors. Impact investors therefore need to develop the tools and skill sets to accurately assess these claims in order to allocate capital effectively to those companies making the biggest positive impact.
IMM has been a core part of our public market impact investing strategies since 2015. However, IMM in private markets, and particularly in VC, has specific considerations we believe investors should take into account. In our view, the following points are the most crucial:
We believe there are a few best practices that can help companies and investors navigate the unique challenges of measuring impact in this constantly evolving space. Below, we share four ways to authentically measure the progress companies create.
Impact measurement and management are essential parts of the impact investing industry. In our view, a holistic, considered and authentic approach to IMM is particularly relevant in venture capital, where the earlier-stage opportunity set can make this process more complicated.
1Source: Global Impact Investment Network, “Getting started with impact measurement and management”. |2Source: Global Impact Investment Network, “Annual Impact Investor Survey 2020”.|3Source: HSBC, “Essence of Enterprise - A new age of Entrepreneurship”.|4Source: Impact Frontiers, “Impact Management Norms”.|5Source: Global Impact Investment Network, IRIS+ system.
URL References
Related Insights
Stay up to date with the latest market insights and our point of view.
Governance best practices in public markets
For private companies approaching the public markets, we highlight the corporate governance best practices that can help pave strong relationships with public market investors.
Understanding private equity performance
We dive deep on best practices for measuring and benchmarking private equity performance. In addition, we outline the J-curve and the impact of fund lifecycle on returns.
WellSaid: Partnering with portfolio companies
Co-head of private investing Michael Carmen explores how we partner with portfolio companies to help them along the "last mile from the private market to the public market" including on key ESG issues for private companies to consider.
Biotech for the next decade: Private market innovations
We explore our latest research in private biotech innovation across immunomodulatory therapies, precision oncology, antibody drug conjugates, radiopharmaceuticals, genetic medicines, and a range of other novel treatment modalities.
Mid-year Alternative Investment Outlook
This collection provides timely ideas across the spectrum of alternative investments -- including hedge funds, private equity, and private credit.
The state of venture capital markets
Co-head of private investments Michael Carmen shares his outlook for venture capital markets, including the state of deal flow, valuations, and the IPO market.
Private biotech market: Innovation, valuations, and capital efficiency
Co-heads of biotech private investments I-hung Shih and Nilesh Kumar join host Thomas Mucha to explore today's private biotech market, highlighting the state of deal flow, valuations, and innovation.
Cybersecurity for private companies
We highlight today's rising cybersecurity risks, explore how they impact private companies, discuss key regulatory considerations, and share best practices for companies facing these threats.
Private biotech: Innovation amid disruption
We explore the state of the private biotech market, highlight key areas of innovation, and share three themes we expect to continue.
URL References
Related Insights